Alopecia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Alopecia Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • May 2022 •
  • 147 pages •
  • Report ID: 6197481 •
  • Format: PDF
The global alopecia treatment market reached a value of US$ 3 Billion in 2021.

Looking forward, the analyst expects the market to reach US$ 3.9 Billion by 2027, exhibiting a CAGR of 4.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Alopecia, also known as hair loss, is an autoimmune skin disease affecting the growth of healthy hair follicles on the scalp, face, and other areas of the body. Its treatment is dependent on numerous factors, including the type of alopecia areata, patient age, and the extent of hair loss. Alopecia treatment aims to block the immune system attack and stimulate the regrowth of hair. Nowadays, phototherapy or low light laser therapy (LLLT) is gaining traction around the world as it is safer, tolerable, and less invasive than other treatments.

Alopecia Treatment Market Trends:
As age significantly leads to the gradual thinning of hair, the expanding geriatric population worldwide represents one of the key factors bolstering the market growth. Besides this, stressful lifestyles, the escalating cases of malnutrition, and the rising number of individuals with certain medical conditions, such as diabetes, lupus, and persistent weight loss, are other factors increasing the risk of hair loss. This, along with the growing focus on improving physical health and the increasing access to healthcare services, is positively influencing the need for alopecia treatments across the globe. Moreover, due to the escalating demand for combination therapies with enhanced effectiveness and minimal side effects, cytokine and regenerative cell therapies are widely being used to treat different types of alopecia. Apart from this, several drugs, such as corticosteroid and minoxidil, are available for treating children with alopecia. Additionally, the improving healthcare infrastructure and increasing concerns among parents about the health of their children are contributing to the market growth. Furthermore, a considerable number of drugs are under late-stage clinical trials, which is anticipated to provide a positive market outlook.

Key Market Segmentation:
the analyst provides an analysis of the key trends in each sub-segment of the global alopecia treatment market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on, drug type, indication, gender, route of administration and distribution channel.

Breakup by Drug Type:
Minoxidil
Finasteride
Others

Breakup by Indication:
Androgenic Alopecia
Alopecia Areata
Alopecia Totalis
Others

Breakup by Gender:
Male
Female

Breakup by Route of Administration:
Oral
Topical
Injectable

Breakup by Distribution Channel:
Hospitals
Retail Pharmacies
Online Pharmacies

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Aclaris Therapeutics Inc., Cellmid Limited, Cipla Limited, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, HCell Inc., Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Taisho Pharmaceutical Holdings Co. Ltd and Teva Pharmaceutical Industries Ltd.



Key Questions Answered in This Report:

How has the global alopecia treatment market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global alopecia treatment market?
What are the key regional markets?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the gender?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global alopecia treatment market and who are the key players?
What is the degree of competition in the industry?